Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML - ScienceDirect
Cancers | Free Full-Text | Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia | HTML
Week 3 Table | PDF | Multiple Myeloma | Immune System
CD33 Antibodies - Beckman Coulter
Frontiers | The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice | Immunology
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML - ScienceDirect
IJMS | Free Full-Text | Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33 | HTML